The £3 million Tumour Profiling Unit (TPU) in London is to research the use of DNA mapping to identify patients' cancer strains. It is hoped the technique will pave the way for radical new forms of diagnosis, surveillance and targeted therapy.
One aim of the research is to develop "liquid biopsies" that search for free-floating cancer DNA in samples of blood. This can then be used to identify and monitor cancer sub-types that are likely to respond to particular drugs.
Another, controversial, proposal is the use of "mouse avatars" that mirror a patient's disease progression.
Tumour samples from patients will be implanted into mice which will then be observed closely to spot early signs of molecular change and resistance to therapy.
More top news
Wigan Athletic have received another blow after drinks company iPro Sport ended their sponsorship deal with the Championship club.
Ofsted chief says pupils' 'physical and educational welfare is at serious risk' at seven schools in the borough
Art collectors have the chance to get their hands on a 100-year-old watercolour of Munich registry office by Nazi dictator Adolf Hitler.